NKORE Discovery in Cancer Treatment Featured Live in Moonshot4Kids Congressional and Administration Briefing Recap Event

0
247


Dr. Jewett and Tracy Ryan give live presentation on NKORE Biotherapeutics discovery, Saturday, Sept 10

Dr. Jewett and Tracy Ryan give reside presentation on NKORE Biotherapeutics discovery, Saturday, Sept 10

Accelerate Action!  Support H. Res. 404 at passhres404.com

Help us make historical past for childhood most cancers consciousness. Tell your Rep to help H. Res. 404 in the present day!

Janet Demeter, childhood cancer advocate, meets President Biden at the Moonshot Announcement 2-2-22

Childhood most cancers advocate Janet Demeter meets President Biden on the 2/2/2022 Cancer Moonshot Announcement, and shares the significance of consciousness for childhood mind most cancers

In the spirit of the Cancer Moonshot, H. Res. 404 offers a platform of consciousness for unseen struggling and dying, improvements in analysis, and hope for a remedy.

The outcomes we’re seeing are giving us…hope that we are going to quickly be capable of supply higher remedies for kids and adults alike that repair the core downside versus focusing on the illness with toxicity.”

— Tracy Ryan, CCO NKORE Biotherapeutics

LOS ANGELES, CA, USA, September 4, 2022 /EINPresswire.com/ — On September 10, 2022, NKORE Biotherapeutics will take center-stage in the anticipated streaming replay presentation of the Moonshot4Kids Congressional/OSTP Briefing on Childhood Brain Cancer, an occasion initially introduced in-part on May 17, 2022 in the Rayburn House Office Building in Washington DC, and hosted by the Offices of Congresswoman Debbie Dingell (D-MI-12), Congressman David Joyce (R-OH-14), with opening remarks from Congressman Michael McCaul (R-TX-10), founder and Co-Chairman of the Childhood Cancer Caucus. Presented by The Cure Starts Now Foundation and the Carson Leslie Foundation, and produced by DIPG Advocacy Group underneath the auspices of Jack’s Angels Inc (Agua Dulce, CA), the briefing was supposed to teach and inform Congress and the Biden Administration’s Cancer Moonshot Team about DIPG and childhood mind most cancers, the #1 cancer-related explanation for dying in kids in the USA as described in the DIPG Awareness Resolution (H. Res. 404), which suggests prioritizing pediatric and high-mortality charge cancers for analysis into cures and a rise in federal funding for childhood cancers in normal.

“Despite great progress made over the last decade in childhood cancer legislation and parent-funded discoveries in research, virtually nothing has changed for children with DIPG and most childhood cancers; awareness is the missing link,” remarks Janet Demeter, President of Jack’s Angels and a founding father of DIPG Advocacy Group; “DIPG is still a death sentence with the same standard of care as when Neil Armstrong’s daughter died of it in 1962.” The group’s briefing in May launched the ultimate marketing campaign to have the House of Representatives move H. Res. 404 throughout this session of Congress, after almost 7 years of training in regards to the realities of childhood mind most cancers, and lobbying on her personal for households everywhere in the nation with the assistance of different childhood most cancers advocates like Paul Miller (Littleton, CO), DIPG Advocacy Group’s founding accomplice, and Marcelo Ortigao (Fort Collins CO), Science and Medical Advisor to the group.

At 7pm ET on Saturday, Sept. 10, the general public streaming presentation of briefing testimony from business professionals, among the world’s most revered physician-researchers in pediatric neuro-oncology, philanthropists, and additionally households and survivors, shall be adopted by a particular, reside presentation and Q&A session from Tracy Ryan (Los Angeles, CA) and Dr. Anahid Jewett (UCLA), the CCO and CSO of NKORE Biotherapeutics, on NKORE’s method to “Super Charging” allogeneic Natural Killer Cells. Developments in analysis and discovery herald a brand new period of immuno-therapeutic medication for the remedy of most cancers in sufferers of all ages. A founding father of NKORE Biotherapeutics, Ryan humbly attributes all of her entrepreneurial ambitions, together with additionally the founding of Cannakids, to at least one sole trigger: to discover a remedy for her daughter, as a result of, “…before, there was nothing.”

“After our infant daughter Sophie was diagnosed with a low-grade brain tumor at 8 1/2 months old, my husband and I decided then and there to dedicate our lives to curing her. From our days of trailblazing the use of medical cannabis for pediatric diseases to our Netflix documentary ‘Weed the People’, working successfully with patients all over the world has driven us to do more. With the launch of my cancer immunotherapy company NKore BioTherapeutics, we are now focused on repairing the very part of the immune system which, when it fails, is why we get cancer: the Natural Killer Cell System. Backed by over 30 years of research from world renowned UCLA-based cancer research scientist Dr. Anahid Jewett, the results we are seeing are giving us incredible hope that we will soon be able to offer better treatments for children and adults alike that fix the core problem versus targeting the disease with toxicity.”

“Tracy’s dedication to saving her daughter exemplifies the spirit of the Cancer Moonshot with integrity of purpose, the uncompromisable urgency for expedience, and holistic innovation in medicine.” Demeter had, in half, publicly criticized the Cancer Moonshot Announcement on 2/2/2022 for the neglect to say childhood most cancers, the #1 disease-related killer of American kids. According to Demeter the absence was par for the course as the present medical analysis investment-culture considers the “impactfulness” of analysis relative to investor pursuits, not smaller affected person populations as is the case for all childhood cancers. “The conversation and communication between the childhood cancer community and the Administration has been so helpful this year, that our children may be figured more prominently and urgently in the Cancer Moonshot. This briefing opportunity, as well as the resolution itself, has provided a platform–now one of many–for this communication, both with Congress and the Administration. We are honored to feature NKORE and this breakthrough discovery which could play an important role in meeting the long-time needs, and demands, of the childhood cancer community for effective therapies designed for children that are lower in toxicity.”

To help subsequent steps for the DIPG Awareness Resolution (H. Res. 404) to be moved nearer to consideration for House floor-scheduling, a video of choose briefing content material has been produced to be shared with the Offices of the Health Subcommittee Chair, the Energy and Commerce Committee Chair, the House Leadership Team, in addition to the Cancer Moonshot Team. September tenth streaming data and the September 18th encore replay could be discovered at www.dipgadvocacy.org, and could be adopted from the fb pages for Childhood Cancer Talk Radio, and Jack’s Angels Foundation. For extra details about NKORE Biotherapeutics, go to www.NKORE.com.

Janet Demeter
Jack’s Angels Inc
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn

The Cure Starts Now / Childhood Cancer and DIPG/DMG Facts





Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here